Data gathered: January 31
AI Stock Analysis - Atricure (ATRC)
Analysis generated January 24, 2025. Powered by Chat GPT.
AtriCure, Inc. is a medical device company that provides innovative products and solutions designed for the treatment of atrial fibrillation (AF) and related conditions. The company's minimally invasive surgical products are primarily directed at treating patients with persistent and long-standing persistent forms of AF. AtriCure is also focused on research and development of cutting-edge cardiac technologies, aiming to address unmet clinical needs.
Stock Alerts - Atricure (ATRC)
 |
Atricure | January 30 Price is down by -5.3% in the last 24h. |
|
Atricure | January 26 Employee Rating is down by 2.1% over the last month. |
|
Atricure | January 15 Price is up by 5% in the last 24h. |
|
Atricure | January 13 Price is up by 6.8% in the last 24h. |
Alternative Data for Atricure
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 75 | Sign up | Sign up | Sign up |
| Sentiment | 96 | Sign up | Sign up | Sign up |
| Webpage traffic | 14,000 | Sign up | Sign up | Sign up |
| Employee Rating | 92 | Sign up | Sign up | Sign up |
| Google Trends | 38 | Sign up | Sign up | Sign up |
| Patents | 150 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 11 | Sign up | Sign up | Sign up |
| Facebook Followers | 1,277 | Sign up | Sign up | Sign up |
| Instagram Followers | 775 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 384 | Sign up | Sign up | Sign up |
| Twitter Followers | 2,589 | Sign up | Sign up | Sign up |
| Twitter Mentions | 7 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 1,110 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 94 | Sign up | Sign up | Sign up |
| Linkedin Employees | 1,250 | Sign up | Sign up | Sign up |
About Atricure
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally.
| Price | $40.60 |
| Target Price | Sign up |
| Volume | 713,130 |
| Market Cap | $1.98B |
| Year Range | $19.86 - $42.4 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Earnings Date | February 12 '25 |
| Industry | Medical & Dental Instruments |
In the news
 |
Autonomix Medical (NASDAQ:AMIX) and AtriCure (NASDAQ:ATRC) Critical SurveyJanuary 25 - ETF Daily News |
 |
AtriCure (NASDAQ:ATRC) Stock Price Expected to Rise, Needham & Company LLC Analyst SaysJanuary 24 - ETF Daily News |
|
AtriCure (NASDAQ:ATRC) Sets New 12-Month High Following Analyst UpgradeJanuary 23 - ETF Daily News |
 |
Why AtriCure, Inc. (ATRC) Is Skyrocketing NowJanuary 23 - Yahoo Entertainment |
 |
Orthofix Medical (NASDAQ:OFIX) vs. AtriCure (NASDAQ:ATRC) Financial ReviewJanuary 20 - ETF Daily News |
|
AtriCure (NASDAQ:ATRC) Given Buy Rating at Needham & Company LLCJanuary 14 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 116M | 29M | 87M | -7.9M | -5.3M | -0.170 |
| Q2 '24 | 116M | 29M | 87M | -8M | -7M | -0.170 |
| Q1 '24 | 109M | 28M | 81M | -13M | -9.3M | -0.280 |
| Q4 '23 | 107M | 27M | 80M | -9.8M | -5.7M | -0.210 |
| Q3 '23 | 98M | 24M | 74M | -9.1M | -5.3M | -0.200 |
Insider Transactions View All
| Yuen Maggie filed to sell 8,970 shares at $24.1. August 19 '24 |
| Privitera Salvatore filed to buy 103,290 shares at $22.3. May 31 '24 |
| Noznesky Justin J filed to sell 71,284 shares at $24.1. May 3 '24 |
| Noznesky Justin J filed to sell 72,784 shares at $30.4. April 3 '24 |
| Dahlquist Karl S. filed to sell 50,954 shares at $32.2. March 20 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Align TechnologyALGN |
$225.36 0% | 40 |
 |
DentsplyXRAY |
$20.31 0% | 32 |
 |
LeMaitre VascularLMAT |
$100.15 0% | 57 |
 |
iRhythm TechnologiesIRTC |
$107.74 0% | 49 |
 |
NovoCureNVCR |
$25.51 0% | 53 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Josh Gottheimer |
Aug 15, 24 | Buy | $1K - $15K |
| Josh Gottheimer |
Jul 9, 24 | Sell | $1K - $15K |
Read more about Atricure (ATRC) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Atricure?
The Market Cap of Atricure is $1.98B.
When does Atricure report earnings?
Atricure will report its next earnings on February 12 '25.
What is the current stock price of Atricure?
Currently, the price of one share of Atricure stock is $40.60.
How can I analyze the ATRC stock price chart for investment decisions?
The ATRC stock price chart above provides a comprehensive visual representation of Atricure's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Atricure shares. Our platform offers an up-to-date ATRC stock price chart, along with technical data analysis and alternative data insights.
Does ATRC offer dividends to its shareholders?
As of our latest update, Atricure (ATRC) does not offer dividends to its shareholders. Investors interested in Atricure should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Atricure?
Some of the similar stocks of Atricure are Align Technology, Dentsply, LeMaitre Vascular, iRhythm Technologies, and NovoCure.
.